The estimated Net Worth of Alexander Azoy is at least $72 Tisíc dollars as of 13 August 2024. Mr Azoy owns over 1,357 units of Unity Biotechnology Inc stock worth over $26,698 and over the last 6 years he sold UBX stock worth over $45,308.
Sign up
Mr Azoy UBX stock SEC Form 4 insiders trading
Mr has made over 3 trades of the Unity Biotechnology Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 1,357 units of UBX stock worth $20,314 on 13 August 2024.
The largest trade he's ever made was selling 1,357 units of Unity Biotechnology Inc stock on 13 August 2024 worth over $20,314. On average, Mr trades about 242 units every 37 days since 2019. As of 13 August 2024 he still owns at least 19,070 units of Unity Biotechnology Inc stock.
You can see the complete history of Mr Azoy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Alexander Azoy biography
Alexander Azoy is the VP of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer at Unity Biotechnology Inc.
How old is Mr Azoy?
Mr Azoy is 45, he's been the VP of Fin., Chief Accounting Officer a Controller & Principal Accounting Officer of Unity Biotechnology Inc since . There are 22 older and no younger executives at Unity Biotechnology Inc. The oldest executive at Unity Biotechnology Inc is David Lacey, 67, who is the Independent Director.
What's Mr Azoy's mailing address?
Alexander's mailing address filed with the SEC is C/O ARCUS BIOSCIENCES, INC., 3928 POINT EDEN WAY, HAYWARD, CA, 94545.
Insiders trading at Unity Biotechnology Inc
Over the last 7 years, insiders at Unity Biotechnology Inc have traded over $9,012,473 worth of Unity Biotechnology Inc stock and bought 3,200 units worth $28,480 . The most active insiders traders include Kristina Burow, Robert Nelsen a Nathaniel E David. On average, Unity Biotechnology Inc executives and independent directors trade stock every 54 days with the average trade being worth of $65,316. The most recent stock trade was executed by Alexander Hieu Nguyen on 2 August 2024, trading 154 units of UBX stock currently worth $236.
What does Unity Biotechnology Inc do?
unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at www.unitybiotechnology.com.
What does Unity Biotechnology Inc's logo look like?
Complete history of Mr Azoy stock trades at Arcus Biosciences Inc a Unity Biotechnology Inc
Unity Biotechnology Inc executives and stock owners
Unity Biotechnology Inc executives and other stock owners filed with the SEC include:
-
Keith Leonard,
Chairman of the Board -
Margo Roberts,
Independent Director -
Nathaniel David,
President, Co-Founder, Director -
Dr. Anirvan Ghosh,
CEO & Director -
Dr. Jamie Dananberg M.D.,
Chief Medical Officer -
Dr. Jamie Dananberg,
Chief Medical Officer -
Lynne Marie Sullivan,
CFO & Head of Corp. Devel. -
Paul Berns,
Independent Director -
Graham Cooper,
Independent Director -
David Lacey,
Independent Director -
Kristina Burow,
Independent Director -
Camille Samuels,
Independent Director -
Robert Nelsen,
Director -
Dr. Nathaniel E. David A.B., Ph.D.,
Co-Founder & Exec. Director -
Luis Visoso,
Director -
Mary Campbell,
Director -
Jamie Dananberg,
Chief Medical Officer -
Tamara Tompkins,
General Counsel and Corporate Secretary -
Dan Marquess,
Chief Scientific Officer -
Lynne Sullivan,
Chief Financial Officer, Chief Accounting Officer -
Anirvan Ghosh,
Chief Executive Officer, Director -
Dr. Nathaniel E. David,
Co-Founder & Exec. Director -
Susan Lundeen Smuck,
Chief HR Officer -
Dr. Przemyslaw Sapieha Ph.D.,
Chief Scientific Advisor -
Alexander Azoy,
VP of Fin., Chief Accounting Officer, Controller & Principal Accounting Officer -
Nathan Guz Ph.D.,
VP of Operations -
Daohong Zhou M.D.,
Founder -
Dr. Judith Campisi,
Founder -
Dr. Jan M. van Deursen,
Founder -
Alexander Azoy,
See Remarks -
Alexander Hieu Nguyen,
Chief Legal Officer -
Ii Robert C. Goeltz,
Chief Financial Officer -
Venture Partners Vii, Llcar...,
-
Michael P. Samar,
-
Gilmore Neil O'neill,